Ten Years of Change in Bariatric/Metabolic Surgery in the Asia–Pacific Region with COVID-19 Pandemic: IFSO-APC National Reports 2021 - Summary - MDSpire
Advertisement
Ten Years of Change in Bariatric/Metabolic Surgery in the Asia–Pacific Region with COVID-19 Pandemic: IFSO-APC National Reports 2021
To summarize changes in bariatric/metabolic surgery in the Asia-Pacific region over the past decade, including specific trends and assess the impact of the COVID-19 pandemic.
Key Findings:
The number of bariatric/metabolic surgeries increased from 28,773 in 2013 to 70,573 in 2018, a 2.5-fold increase.
Obesity prevalence and type 2 diabetes mellitus (T2DM) rates were reported for 2010 and recent years, showing significant public health concerns.
COVID-19 had a notable impact on the delivery and accessibility of bariatric/metabolic surgeries, with a reported X% decrease in procedures during the pandemic.
Interpretation:
The data indicate a significant rise in the prevalence of obesity and T2DM, alongside an increase in surgical interventions, highlighting the urgent need for effective management strategies in the region.
Limitations:
Data collection relied on self-reported information from national societies, which may introduce bias and affect the reliability of the findings.
Variability in healthcare systems and reporting practices across countries may affect comparability.
Conclusion:
The report underscores the evolving landscape of bariatric/metabolic surgery in the Asia-Pacific region, emphasizing the need for continued adaptation in response to public health challenges, including the COVID-19 pandemic, and recommending specific strategies for improvement.
by Masayuki Ohta, Soo Min Ahn, Yosuke Seki, Wah Yang, Simon Kin-Hung Wong, Suthep Udomsawaengsup, Jeffrey M. Hamdorf, Manish Khaitan, Nik Ritza Kosai, Weu Wang, June Lee, Reno Rudiman, Thejana Wijeratne, Edward Oliveros, Cunchuan Wang, Kazunori Kasama
